☰

Tanner M. Johanns, Ph.D. - Publications

Affiliations: 
2010 Microbiology, Immunology and Cancer Biology University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Immunology
Tree Info Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Wang AZ, Mashimo BL, Schaettler MO, Sherpa ND, Leavitt LA, Livingstone AJ, Khan SM, Li M, Anzaldua-Campos MI, Bradley JD, Leuthardt EC, Kim AH, Dowling JL, Chicoine MR, Jones PS, ... ... Johanns TM, et al. Glioblastoma-infiltrating CD8+ T cells are predominantly a clonally expanded GZMK+ effector population. Cancer Discovery. PMID 38416133 DOI: 10.1158/2159-8290.CD-23-0913  0.445
2023 Schaettler MO, Desai R, Wang AZ, Livingstone AJ, Kobayashi DK, Coxon AT, Bowman-Kirigin JA, Liu CJ, Li M, Bender DE, White MJ, Kranz DM, Johanns TM, Dunn GP. TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma. Journal For Immunotherapy of Cancer. 11. PMID 36808076 DOI: 10.1136/jitc-2022-006121  0.304
2022 Khan SM, Desai R, Coxon A, Livingstone A, Dunn GP, Petti A, Johanns TM. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors. Journal For Immunotherapy of Cancer. 10. PMID 36543376 DOI: 10.1136/jitc-2022-005293  0.424
2022 Bowman-Kirigin JA, Desai R, Saunders BT, Wang AZ, Schaettler MO, Liu CJ, Livingstone AJ, Kobayashi DK, Durai V, Kretzer NM, Zipfel GJ, Leuthardt EC, Osbun JW, Chicoine MR, Kim AH, ... ... Johanns TM, et al. The conventional dendritic cell 1 subset primes CD8+ T cells and traffics tumor antigen to drive anti-tumor immunity in the brain. Cancer Immunology Research. PMID 36409838 DOI: 10.1158/2326-6066.CIR-22-0098  0.311
2019 Johanns TM, Miller CA, Liu CJ, Perrin RJ, Bender D, Kobayashi DK, Campian JL, Chicoine MR, Dacey RG, Huang J, Fritsch EF, Gillanders WE, Artyomov MN, Mardis ER, Schreiber RD, et al. Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma. Oncoimmunology. 8: e1561106. PMID 30906654 DOI: 10.1080/2162402X.2018.1561106  0.345
2019 Liu C, Schaettler M, Bowman-Kirigin J, Bender D, Kobayashi DK, Miller CA, Johanns TM, Dunn GP. Combination Immune Treatment of a Highly Aggressive Orthotopic Murine Glioblastoma With Checkpoint Blockade Inhibition and Neoantigen Vaccination Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_153  0.425
2019 Liu C, Schaettler M, Bowman-Kirigin J, Kobayashi D, Miller C, Johanns T, Dunn G. IMMU-09. COMBINATION IMMUNE TREATMENT OF A HIGHLY AGGRESSIVE ORTHOTOPIC MURINE GLIOBLASTOMA WITH CHECKPOINT BLOCKADE AND MULTI-VALENT NEOANTIGEN VACCINATION Neuro-Oncology. 21: vi120-vi121. DOI: 10.1093/Neuonc/Noz175.503  0.418
2018 Woroniecka K, Chongsathidkiet P, Rhodin KE, Kemeny HR, Dechant CA, Farber SH, Elsamadicy AA, Cui X, Koyama S, Jackson CC, Hansen LJ, Johanns TM, Sanchez-Perez L, Chandramohan V, Yu YA, et al. T Cell Exhaustion Signatures Vary with Tumor Type and are Severe in Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29437767 DOI: 10.1158/1078-0432.Ccr-17-1846  0.519
2018 Zolkind P, Przybylski D, Marjanovic N, Nguyen L, Lin T, Johanns T, Alexandrov A, Zhou L, Allen CT, Miceli AP, Schreiber RD, Artyomov M, Dunn GP, Uppaluri R. Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma. Oncotarget. 9: 4109-4119. PMID 29423108 DOI: 10.18632/Oncotarget.23751  0.36
2016 Johanns TM, Ward J, Wilson C, Kobayashi DK, Bender D, Fu Y, Alexandrov A, Artyomov MN, Miller CA, Mardis ER, Dunn GP. 143 Identification of Neoantigen-specific CD8+ T Cells in Two Murine Orthotopic Glioblastoma Models Using Cancer Immunogenomics. Neurosurgery. 63: 158. PMID 28175395 DOI: 10.1227/01.neu.0000489713.52326.9a  0.414
2016 Johanns TM, Ward JP, Miller CA, Wilson C, Kobayashi DK, Bender D, Fu Y, Alexandrov A, Mardis ER, Artyomov MN, Schreiber RD, Dunn GP. Endogenous Neoantigen-specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach. Cancer Immunology Research. PMID 27799140 DOI: 10.1158/2326-6066.Cir-16-0156  0.39
2016 Johanns TM, Ward J, Wilson C, Kobayashi DK, Bender D, Fu Y, Alexandrov A, Artyomov MN, Miller CA, Mardis ER, Dunn GP. 143 Identification of Neoantigen-specific CD8+ T Cells in Two Murine Orthotopic Glioblastoma Models Using Cancer Immunogenomics. Neurosurgery. 63: 158. PMID 27399422 DOI: 10.1227/01.Neu.0000489713.52326.9A  0.504
2011 Ertelt JM, Johanns TM, Mysz MA, Nanton MR, Rowe JH, Aguilera MN, Way SS. Selective culling of high avidity antigen-specific CD4+ T cells after virulent Salmonella infection. Immunology. 134: 487-97. PMID 22044420 DOI: 10.1111/J.1365-2567.2011.03510.X  0.775
2011 Johanns TM, Law CY, Kalekar LA, O'Donnell H, Ertelt JM, Rowe JH, Way SS. Early eradication of persistent Salmonella infection primes antibody-mediated protective immunity to recurrent infection. Microbes and Infection / Institut Pasteur. 13: 322-30. PMID 21134485 DOI: 10.1016/J.Micinf.2010.11.004  0.726
2010 Johanns TM, Ertelt JM, Rowe JH, Way SS. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. Plos Pathogens. 6: e1001043. PMID 20714351 DOI: 10.1371/Journal.Ppat.1001043  0.758
2010 Ertelt JM, Johanns TM, Rowe JH, Way SS. Interleukin (IL)-21-independent pathogen-specific CD8+ T-cell expansion, and IL-21-dependent suppression of CD4+ T-cell IL-17 production. Immunology. 131: 183-91. PMID 20465570 DOI: 10.1111/J.1365-2567.2010.03287.X  0.713
2010 Johanns TM, Ertelt JM, Lai JC, Rowe JH, Avant RA, Way SS. Naturally occurring altered peptide ligands control Salmonella-specific CD4+ T cell proliferation, IFN-gamma production, and protective potency. Journal of Immunology (Baltimore, Md. : 1950). 184: 869-76. PMID 20026741 DOI: 10.4049/Jimmunol.0901804  0.751
2009 Ertelt JM, Rowe JH, Johanns TM, Lai JC, McLachlan JB, Way SS. Selective priming and expansion of antigen-specific Foxp3- CD4+ T cells during Listeria monocytogenes infection. Journal of Immunology (Baltimore, Md. : 1950). 182: 3032-8. PMID 19234199 DOI: 10.4049/Jimmunol.0803402  0.765
2009 Rowe JH, Johanns TM, Ertelt JM, Lai JC, Way SS. Cytotoxic T-lymphocyte antigen 4 blockade augments the T-cell response primed by attenuated Listeria monocytogenes resulting in more rapid clearance of virulent bacterial challenge. Immunology. 128: e471-8. PMID 19191906 DOI: 10.1111/J.1365-2567.2008.03001.X  0.778
2008 Rowe JH, Johanns TM, Ertelt JM, Way SS. PDL-1 blockade impedes T cell expansion and protective immunity primed by attenuated Listeria monocytogenes. Journal of Immunology (Baltimore, Md. : 1950). 180: 7553-7. PMID 18490756 DOI: 10.4049/Jimmunol.180.11.7553  0.764
2005 Goetz CA, Harmon IR, O'Neil JJ, Burchill MA, Johanns TM, Farrar MA. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment. Journal of Immunology (Baltimore, Md. : 1950). 174: 7753-63. PMID 15944278 DOI: 10.4049/Jimmunol.174.12.7753  0.381
Show low-probability matches.